Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Athersys Inc.

Start price
Target price
Perf. (%)
€23.38
30.11.21
€25.00
30.11.22
-71.89%
07.07.22

Could be worthwhile Investment >10% per year
Innovative
Few uniques
buy
Valneva SE

Start price
Target price
Perf. (%)
€29.96
30.11.21
€35.00
30.11.22
-66.46%
12.08.22

Could be very worthwhile Investment >20% year
buy
Dexcom Inc.

Start price
Target price
Perf. (%)
€125.40
30.11.21
-
30.11.22
-27.01%
02.03.22

buy
Astrazeneca ADR

Start price
Target price
Perf. (%)
€49.00
29.11.21
-
29.11.22
29.80%
30.11.22

Could be worthwhile Investment >10% per year
buy
Evotec SE

Start price
Target price
Perf. (%)
€41.50
29.11.21
-
29.11.25
-56.01%
21.03.23

Could be very worthwhile Investment >20% year
Krystal Biotech

Start price
Target price
Perf. (%)
€77.00
29.11.21
-
29.11.22
-19.48%
10.12.21

Probably not worthwhile Investment
buy
Fennec Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.22
29.11.21
-
29.11.22
-16.11%
12.12.21

Could be worthwhile Investment >10% per year
buy
Nanorepro AG

Start price
Target price
Perf. (%)
€9.94
29.11.21
-
29.11.25
-83.35%
11.03.24

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€28.32
29.11.21
-
29.11.22
-65.32%
21.07.22

Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
buy
Medigene AG

Start price
Target price
Perf. (%)
€3.03
29.11.21
-
29.11.22
-21.12%
30.11.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Standard Investments for future growth
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€17.00
28.11.21
-
28.11.22
7.65%
11.12.21

Could be worthwhile Investment >10% per year
Acorda Therapeutics Cdt

Start price
Target price
Perf. (%)
€2.64
28.11.21
-
28.11.22
-77.46%
29.11.22

Risky Investment
buy
Futura Medical

Start price
Target price
Perf. (%)
€0.36
27.11.21
€0.50
27.11.22
30.90%
28.11.22

Could be worthwhile Investment >10% per year
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€5.24
27.11.21
€8.00
27.11.22
-47.90%
28.11.22

Could be worthwhile Investment >10% per year
buy
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€18.36
27.11.21
€19.00
27.11.22
-50.44%
28.11.22

Could be worthwhile Investment >10% per year
buy
Onxeo S.A.

Start price
Target price
Perf. (%)
€0.41
27.11.21
€0.60
27.11.22
-56.65%
28.11.22

Could be worthwhile Investment >10% per year
buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€1.31
27.11.21
-
27.11.22
11.62%
12.12.21

Risky Investment
buy
Valneva SE

Start price
Target price
Perf. (%)
€28.30
27.11.21
€28.00
27.11.22
-44.88%
30.03.22

Could be worthwhile Investment >10% per year
Very valuable balance sheet
buy
Repligen Corp.

Start price
Target price
Perf. (%)
€264.10
27.11.21
€300.00
31.12.23
-46.31%
08.05.23

Could be worthwhile Investment >10% per year
buy
Bruker Corp.

Start price
Target price
Perf. (%)
€75.50
27.11.21
€100.00
31.12.23
-5.30%
08.05.23

Could be worthwhile Investment >10% per year
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€6.45
27.11.21
€3.30
27.11.22
-52.69%
12.04.22

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€59.95
27.11.21
€75.00
27.11.22
-29.44%
28.11.22

Could be very worthwhile Investment >20% year
Few uniques
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€140.70
27.11.21
€160.00
27.11.22
21.35%
28.11.22

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
Astrazeneca ADR

Start price
Target price
Perf. (%)
€50.60
27.11.21
€60.00
27.11.22
26.48%
28.11.22

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
Boiron S.A.

Start price
Target price
Perf. (%)
€38.05
26.11.21
-
26.11.22
18.79%
27.11.22

Could be worthwhile Investment >10% per year